AzTrials
AzTrials

HealthyNCT07864545

Impact of Dietary Flavanols on Microvascular Function in Young Females During Mental Stress

A study testing High-flavanol cocoa powder and Low-flavanol cocoa powder in people with Healthy, run by University of Birmingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this project is to examine whether flavonoids, which are small molecules naturally present in cocoa, as well as fruits and vegetables such as berries, tea, citrus fruits, apple (typically responsible for giving these foods their strong colours), can be used to protect the human vascular system. Read more about this study

Who is it for?
Ages 18 to 26 years, women onlyHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
High-flavanol cocoa powder and Low-flavanol cocoa powder
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
23 participants
Where
1 siteUnited Kingdom
Study dates
7 Feb 2020to 23 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 26 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female (White or Black African or South Asian ethnicity (with ethnic roots in India, Pakistan, Bangladesh, Sri Lanka, or Nepal)
  • Healthy
  • Aged 18 to 26 years old
  • Do not smoke
  • Do not consume more than 21 units of alcohol per week
  • Have no history of cardiovascular, respiratory, metabolic, liver, inflammatory diseases
Show all 13Show fewer
  • Do not suffer from blood-clotting disorders
  • Do not have allergies or intolerances to any foods
  • Are not on a weight reducing dietary regime
  • Are not taking any dietary supplements, including fatty acids and vitamins
  • Are not taking any long-term medication or been on antibiotics for the last 3 months
  • You do not have an infection at the time of the intervention (e.g. cold)
  • Experience a regular menstrual cycle (controlled by contraceptive pill or otherwise)

Who cannot join

  • Male
  • Not from White European or South Asian Ethnicity
  • Aged 27 years or older
  • Smoke
  • Consume more than 21 units of alcohol per week
  • Have history of cardiovascular, respiratory, metabolic, liver, inflammatory diseases
Show all 13Show fewer
  • Suffer from blood-clotting disorders
  • Have allergies or intolerances to any foods
  • Are on a weight reducing dietary regime
  • Are taking any dietary supplements, including fatty acids and vitamins
  • Are taking any long-term medication or been on antibiotics for the last 3 months
  • Have an infection at the time of the intervention (e.g. cold)
  • Experience a irrregular menstrual cycle

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • School of Sport, Exercise & Rehabilitation Sciences

    Birmingham, West Midlands, B15 2TT

Other trials in United Kingdom

About this study

Official title: Acute Effects of Dietary Flavanols on Microvascular Responses to Mental Stress in White European and South Asian Women: A Randomised, Placebo-controlled, Double-blind, Cross-over Preliminary Intervention Study

The aim of this project is to examine whether flavonoids, which are small molecules naturally present in cocoa, as well as fruits and vegetables such as berries, tea, citrus fruits, apple (typically responsible for giving these foods their strong colours), can be used to protect the human vascular system. Impaired vascular function, as determined by measuring vasodilator responses to various everyday stimuli, can be linked to elevated blood pressure (hypertension) and prevalence of cardiovascular disease. Vascular response to mental stress in particular have been shown to be associated with future risk of cardiovascular disease. Findings from this study could have implications for effective prevention of cardiovascular events in groups with increased cardiovascular risk, such as South Asians and in particular, South Asian women.

Read the detailed description

Psychological stress is linked to cardiovascular health, specifically there is evidence of increased risk of cardiovascular events following episodes of psychological stress, suggesting a vulnerability of the cardiovascular system to the experience of stress.

Individuals of South Asian ethnicity are at higher risk of CVD but also have higher incidence of stress and mood disorders. SA women, in particular, have higher incidence of mental disorders and depression, compared to age-matched WE women, suggesting that this may be a particular vulnerable group.

Flavanols are polyphenolic molecules abundant in cocoa, apples, berries and tea, which have been shown to exert both acute and chronic benefits in the vascular system, by improving conduit artery endothelial function and blood pressure.

However, the effect of flavonoid-rich interventions in ethnic groups at higher risk of CVD, such as South Asians, have not been studied. Intake of flavonoid-rich foods in this population may be able to protect vascular function, particularly in the context of psychological stress.

In this preliminary acute study (randomised, placebo-controlled, double-blind, cross-over intervention) in SA and WE women we assess the effect of an acute cocoa flavanol intervention on the microvascular and cardiovascular responses to acute mental stress. We further compare the impact of flavanols on microvascular responses between women who showed vasodilation in comparison to women that exhibit vasoconstriction during mental stress.

Conditions
Healthy
Being tested
High-flavanol cocoa powder, Low-flavanol cocoa powder
Keywords
microvascular function, flavanols, polyphenols, cocoa, mental stress, female, south asian, white european, near-infrared spectroscopy, vasoconstriction, vasodilator
Medical subject headings
Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-flavanol cocoa powderDietary supplement

    12 g of fat-reduced natural cocoa powder containing 695 mg of total flavanols, including 150 mg (-)-epicatechin

  • Low-flavanol cocoa powderDietary supplement

    12 g of fat-reduced alkalized cocoa powder containing 5.6 mg of total flavanols

Study groups in NCT07864545
Study groupRoleWhat they receive
High-flavanol cocoa powderExperimental12 g of fat-reduced natural cocoa powder containing 695 mg of total flavanols, including 150 mg (-)-epicatechin
Receives: Dietary Supplement: High-flavanol cocoa powder
Low-flavanol cocoa powderPlacebo comparator12 g of fat-reduced alkalized cocoa powder containing 5.6 mg of total flavanols
Receives: Dietary Supplement: Low-flavanol cocoa powder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Forearm oxygen saturation (NIRS) during mental stress (SO2)

    Forearm levels of tissue saturation (SO2) will be assessed by functional Near-Infrared Spectroscopy (fNIRS). The NIRS device measures changes in chromophore concentrations of oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb), providing depth-resolved measures of total tissue oxygen saturation: oxyHb /(oxyHb+deoxyHb)

    Measured: Change from pre-intervention baseline to 1. 5 hours post-intervention (during mental stress)

Secondary outcomes (6)
  1. Forearm total haemoglobin (NIRS) during mental stress (total Hb)

    Forearm levels of tissue saturation (totalHb) will be assessed by functional Near-Infrared Spectroscopy (fNIRS). The NIRS device measures changes in chromophore concentrations of oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb), providing depth-resolved measures of changes in total haemoglobin, which is an index of tissue perfusion/blood flow: oxyHb+deoxyHb

    Measured: Change from pre-intervention to 1.5 hours post-intervention (during mental stress)

  2. Beat-to-beat systolic blood pressure (SBP)

    Beat-to-beat systolic blood pressure (SBP) will be measured using a Finometer (mmHg)

    Measured: Change from pre-intervention baseline to 1.5 hour post-intervention (during mental stress)

  3. Beat-to-beat diastolic blood pressure (DBP)

    Beat-to-beat diastolic blood pressure (DBP) will be measured using a Finometer (mmHg)

    Measured: Change from pre-intervention to 1. 5 hours post-intervention (during mental stress)

  4. Beat-to-beat mean arterial pressure (MAP)

    Beat-to-beat mean arterial pressure (MAP) will be estimated from beat to beat diastolic and systolic blood pressure

    Measured: Change from pre-intervention to 1. 5 hours post-intervention (during mental stress

  5. Forearm Vascular Conductance index (FVC) during mental stress

    Forearm levels of vascular conductance (FVC) will be assessed by functional Near-Infrared Spectroscopy (fNIRS). The NIRS device measures changes in chromophore concentrations of oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb), which is used to estimate totalHb. Pulsatile (beat to beat) Arterial Blood pressure will be monitored using a Finometer® MIDI (Finapres Medical Systems) during mental stress. FVC index will be estimated by dividing ∆totalHb by Mean Arterial Blood pressure

    Measured: Change from pre-intervention to 1. 5 hours post-intervention (during mental stress)

  6. Heart rate (HR) during mental stress

    Heart rate (HR, bpm) is assessed using an electrocardiogram.

    Measured: Change from pre-intervention to 1. 5 hours post-intervention (during mental stress)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2026
  2. Study start7 Feb 2020
  3. Primary completion23 Feb 2023
  4. Study completion23 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07864545
Sponsor's protocol ID
ERN17_1755B
Status last verified
Aug 2026
First submitted
2 Sep 2026
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing High-flavanol cocoa powder and Low-flavanol cocoa powder in people with Healthy, run by University of Birmingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Forearm oxygen saturation (NIRS) during mental stress (SO2) (time frame: Change from pre-intervention baseline to 1. 5 hours post-intervention (during mental stress)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in